Ebit Изменить Дата
Agios Pharmaceuticals USD -110.55M 527K 2026-06
ALKERMES USD 36.59M 102.52M 2026-09
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Amgen USD 4.68B 65M 2026-09
Baxter International USD 314M 38M 2026-09
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
Biogen USD 419.5M 663.3M 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Cara Therapeutics USD -7.05M 1.11M 2026-03
Cipla INR 10.43B 1.55B 2026-09
Dr.Reddys Laboratories INR 12.16B 8.91B 2026-09
Eisai JPY 24.73B 35.04B 2026-06
Eli Lilly USD 13.09B 635M 2026-09
Exelixis USD 268.42M 20.01M 2026-09
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.86B 251M 2026-09
Grifols EUR 320.55M 91.01M 2025-12
Halozyme Therapeutics USD -60.68M 3.04M 2026-09
Incyte USD -707.47M 1.41B 2026-09
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
MacroGenics USD -65.25M 33.36M 2026-06
Merck USD 7.33B 6.49B 2026-09
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Neurocrine Biosciences USD 343M 123.1M 2026-09
Novartis USD 5.14B 411M 2026-09
Pfizer USD 4.85B 5.03B 2026-09
Roche Holding CHF 11.46B 1.91B 2026-06
Sarepta Therapeutics USD -9.04M 22.33M 2026-09
Takeda JPY 205.32B 3.9B 2026-09
Teva Pharmaceutical Industries USD 1.19B 954M 2026-09
Xencor USD -36.6M 41.26M 2026-06